£4.5M
The Bristol based biotech startup secured £4.5m from Eos Advisory, Calculus Capital, and HERmesa to expand manufacturing and drive commercial validation.
E
EnsiliTech
EnsiliTech develops room temperature stabilisation technology for vaccines and biologics.
Bristol, UK
£5.7MTotal raised
EnsiliTech develops room temperature stabilisation technology for vaccines and biologics using silica shell encapsulation. The Bristol based biotech startup aims to eliminate cold chain dependency in pharmaceutical logistics.
Categories
Founders
AS
Asel Sartbaeva
CEO
AS
Asya Sartbaeva
CEO
Investors
- £4.5M
- £1.2M
Funding history
£1.2M
The pre-seed round was led by Science Angel Syndicate and Fink Family Office to develop cold chain-free vaccine technology.